Post COVID-19 Condition
Conditions
Keywords
Sarcopenia, Older people, Health Promotion Program, Post COVID-19
Brief summary
The goal of this clinical trial is to investigate the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok and to test the effectiveness of health promotion program for older people with post-COVID-19 Sarcopenia. The main questions it aim to answer are: • How many is the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok? • Can the health promotion program improve muscle mass and muscle strength in older people with post-COVID-19 Sarcopenia ? Participants will be asked eating protein supplement one scoop /day and exercising 2 times/week for 3 months.
Interventions
1. Protein powder supplementation 25-30 g/day 2. Resistance exercise 2 time/week
Sponsors
Study design
Intervention model description
Phase I: Descriptive survey research Phase II: Quasi-experimental research
Eligibility
Inclusion criteria
* Older people with post-COVID-19 sarcopenia aged more than and equal 60 years * No disabilities * Able to read, write and communicate Thai langue * Live in Bangkok * Moderate post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale * No soy protein allergy * Sign inform consent
Exclusion criteria
* Severe post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale and complicated health problems * Disabilities * Unable to read, write and communicate Thai langue * Soy protein allergy * CKD 4 and CKD 5 * Deny or withdraw from project
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Muscle mass | 3 months | Muscle mass will be measured using BIA and calf circumference in kilograms. |
| Muscle strength | 3 motnhs | Muscle strength will be assessed using hand grip strength in kilograms. |
| Physical fitness | 3 months | Physical fitness will be measured using the Five Times Sit to Stand Test (FTSST) in second. |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of sarcopenia | 3 months |